Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension

ConditionHypertension
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorUniversitas Diponegoro

About this trial

This study aimed to assess and validate the diagnostic utility of a novel Morphology-Voltage-P-wave Score (MVP Score) in identifying left ventricular diastolic dysfunction among patients with hypertension.

Researchers will collect information of patient with hypertension and underwent transthoracal echocardiography assessment. The data consist of demographic data, clinical presentation, laboratory, and echocardiography result were collected by two investigators. Then, the data was analyzed by using IBM SPSS Statistics v26.

Eligibility criteria

Qualifiers

Essential hypertension

Disqualifiers

Secondary or resistant hypertension

LVEF<55%

Congenital heart disease

Infiltrative cardiomyopathy

Trial design

Treatments tested in this trial

  • Echocardiohraphy

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators